Terms: = Breast cancer AND SFRP4, Q6FHJ7, 6424, ENSG00000106483, frpHE, MGC26498, FRPHE, FRP-4 AND Prognosis
3 results:
1. Comprehensive Analysis of the Expression and prognosis for
Wu ZH; Zhang YJ; Yue JX; Zhou T
Cell Transplant; 2020; 29():963689720962479. PubMed ID: 32990024
[TBL] [Abstract] [Full Text] [Related]
2. Epigenetic demethylation of sFRPs, with emphasis on sfrp4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells.
Deshmukh A; Arfuso F; Newsholme P; Dharmarajan A
Int J Biochem Cell Biol; 2019 Apr; 109():23-32. PubMed ID: 30710752
[TBL] [Abstract] [Full Text] [Related]
3. Molecular clustering based on ERĪ± and EIG121 predicts survival in high-grade serous carcinoma of the ovary/peritoneum.
Schlumbrecht MP; Xie SS; Shipley GL; Urbauer DL; Broaddus RR
Mod Pathol; 2011 Mar; 24(3):453-62. PubMed ID: 21102415
[TBL] [Abstract] [Full Text] [Related]